Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Inside the Lab Analytical science, Clinical care, Microscopy and imaging, Histology, Precision medicine, Microscopy and imaging, Technology and innovation

No Label? No Problem!

Today, the gold standard for clinical cancer diagnosis is the visual inspection of H&E-labeled tissue thin sections by a pathologist. Coming in at a close second is the immunohistochemical stain. But proper evaluation of these labeled samples depends on the pathologist’s expertise and the reliability and reproducibility of the staining – aspects that may vary from one situation to the next.

To overcome that obstacle, we established a technique for classification of tissue thin sections that is both label-free and inter-/intra-observer-independent. Our infrared (IR) imaging uses spatially resolved infrared spectra as fingerprints for biochemical disease status. The spectra are automatically classified through bioinformatics, eliminating the variability introduced by a subjective observer.

Credit: Frederik Großerüschkamp and Klaus Gerwert

In this new approach, we image the unstained tissue with an infrared microscope; the image is then classified bioinformatically. The resulting index color images represent the tissue classification – including cancer type, subtype, tissue type, inflammation status, and even tumor grading. As an example, we established a label-free classification of thoracic tumors and their subtypes with a sensitivity of 91 percent and a specificity of 97 percent compared with histological annotation (1). We even achieved an accuracy of 96 percent in the differential diagnosis of the subtypes of lung adenocarcinoma.

The main hindrance for clinical use has been the slow data acquisition speed of older IR imaging systems. In a pioneering study, we showed for the first time that a new laser-based wide-field IR imaging microscope could be used to accurately classify colorectal cancer tissue 180 times faster than previous IR technologies (2) – speed that makes it suitable for clinical use. Colorectal cancer is one of the most common tumor diseases and has high survival rates if caught at an early stage. We studied 100 samples of stage II and III colorectal cancer tissue and 20 tumor-free tissue samples and developed a workflow that enabled us to classify tissue for diagnosis in about 30 minutes (for large thin sections; smaller regions of interest take only a few minutes). Better yet, our new method carried a sensitivity of 96 percent and a specificity of 100 percent. What does this mean? In a very short time, we can gain an understanding of the tumor and its microenvironment without the risk of operator or equipment bias.

The spectral data obtained from the microscope can easily be combined with omics techniques to provide both spatial and molecular resolution. We recently demonstrated this approach for diffuse malignant pleural mesothelioma, a type of cancer mainly caused by asbestos exposure (3) to identify proteins expressed differently in two different tumor subtypes. The next step is detailed bioinformatic analysis to select biomarker candidates from the proteins identified. In our demonstration, all of the clinical immunohistochemistry biomarkers used today for mesothelioma could be identified on a small number of test samples.

Such automated image analysis will one day support pathologists in their daily routines and provide a second opinion in challenging diagnostic situations. It’s our hope that it will pave the way for precise diagnostics and more specific biomarkers in precision medicine.

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. F Großerueschkamp et al., “Marker-free automated histopathological annotation of lung tumour subtypes by FTIR imaging”, Analyst, 140, 2114–2120 (2015). PMID: 25529256.
  2. C Kuepper et al., “Label-free classification of colon cancer grading using infrared spectral histopathology”, Faraday Discuss, 187, 105–118 (2016). PMID: 27064063.
  3. F Großerueschkamp et al., “Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomics”, Sci Rep, 7, 44829 (2017). PMID: 28358042.
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register